# Looking Forward: The Next Generation of Biosimilars #### calendar\_today Date and Time **February 7, 2017** 12:00PM - 01:00PM EST #### pin\_drop Location **Harvard Law School, Wasserstein Hall, Milstein East A (2036), Massachusetts Ave., Cambridge** This event is free and open to the public. Learn more and register at: Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product. This panel of experts will discuss the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective. **Panelists** ***Jennifer DiGiacinto***, RRD International ***Robert S. Langer***, MIT; Consultant, Eagle Biologics ***Benjamin Roin***, MIT Sloan School of Management Moderator: ***Aaron S. Kesselheim***, Brigham and Women’s Hospital/ Harvard Medical School --- Attachments- [ picture\_as\_pdf 17.02.07\_biosimilars\_panel\_poster.pdf ](/sites/g/files/omnuum10026/files/hsci/files/17.02.07_biosimilars_panel_poster.pdf) --- See also:- [ Bioengineering ](/event-disease-area/bioengineering) - [ Bioethics/Health Law ](/event-disease-area/bioethicshealth-law) - [ Biotechnology ](/event-disease-area/biotechnology) - [ For the Public ](/event-type/public) Share on:- [ Facebook ](#) - [ Twitter ](#) - [ Linkedin ](#) Save: [ Add to calendar calendar\_today ](https://www.hsci.harvard.edu/node/985431/event-feed.ics) Copy link link